Zonare announces additional funding
Zonare Medical Systems Inc. this week announced that the company has closed a round of funding, adding approximately $34 million in additional equity funding.
Zonare, who is currently developing an ultrasound system utilizing patented Zone Sonography technology, said the funds will be used to bring the system to the "high performance ultrasound market."
Both previous and new investors in the funding round include Montagu Newhall Associates, Kaiser Permanente Ventures, Earlybird Venture Capital, Frazier Healthcare Ventures, Draper Fisher Jurvetson, Merrill Lynch Ventures, CB Health Ventures, Mosaix Ventures, Siemens Venture Capital nGmbH, and Ascension Health Ventures.
Zonare's ultrasound platform will provide clinical outcomes for a wide variety of imaging needs in general imaging, obstetrics, gynecology, cardiology, vascular and other emerging ultrasound applications, the Mountain View, Calif.-based company said.
Zonare, who is currently developing an ultrasound system utilizing patented Zone Sonography technology, said the funds will be used to bring the system to the "high performance ultrasound market."
Both previous and new investors in the funding round include Montagu Newhall Associates, Kaiser Permanente Ventures, Earlybird Venture Capital, Frazier Healthcare Ventures, Draper Fisher Jurvetson, Merrill Lynch Ventures, CB Health Ventures, Mosaix Ventures, Siemens Venture Capital nGmbH, and Ascension Health Ventures.
Zonare's ultrasound platform will provide clinical outcomes for a wide variety of imaging needs in general imaging, obstetrics, gynecology, cardiology, vascular and other emerging ultrasound applications, the Mountain View, Calif.-based company said.